Les carcinomes épidermoïdes du col utérin à l’Institut du cancer de Dakar

Dem, Ahmadou; Dieng, MM; Traoré, B.; Gaye, M.; Diop, Mame-Kany; Touré, Papa Souleymane

doi:10.1684/san.2008.0094

Cited by 10 publications

(9 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Le cancer invasif du col est le premier cancer de la femme dans les pays en voie de dé veloppement [2][3][4][5] qui sont par ailleurs des pays affecté s par le VIH/Sida. Si le rôle du Papillomavirus humain (HPV) est é tabli dans la survenue du cancer du col de l'uté rus [6,7], de nombreux travaux ont montré l'implication du VIH dans la survenue des lé sions pré cancé reuses du col [8,9].…”

Section: Introductionunclassified

Dysplasies cervicales chez les femmes séropositives pour le VIH en zone de forte prévalence de l’infection

Koffi¹,

Serdouma²,

Mbolissa-Nguérékoudou³

et al. 2010

Gynécologie Obstétrique & Fertilité

View full text Add to dashboard Cite

Section: Introductionunclassified

Dysplasies cervicales chez les femmes séropositives pour le VIH en zone de forte prévalence de l’infection

Koffi¹,

Serdouma²,

Mbolissa-Nguérékoudou³

et al. 2010

Gynécologie Obstétrique & Fertilité

View full text Add to dashboard Cite

“…Arm lymphedema results were too heterogeneous to reliably estimate prevalence or incidence. Two studies suggest that the prevalence of leg lymphedema may be between 7% and 13% (22,40), while only one study estimated incidence of leg lymphedema, estimating it to be 59.1%, focusing speci cally on Brazilian patients following ilioinguinal lymphadenectomy (20).…”

Section: Discussionmentioning

confidence: 99%

“…The prevalence estimates were similar; 7.0% (95% CI 3 -15) (22), 11.0% (95% CI 8 -15) (40) and 13% (95% CI 7 -23) (50). The three studies (22,40,50) that reported on leg lymphedema following cervical cancer reported a pooled prevalence of 10% (95% CI 7 -13) with considerable heterogeneity. The method of measurement of lymphedema was self-report and none of these studies explored leg lymphedema risk factors.…”

Section: Prevalence Of Leg Lymphedema Following Gynecological Cancer mentioning

confidence: 91%

“…Of the ve studies reporting on leg lymphedema, three focused on the prevalence of leg lymphedema secondary to cervical cancer treatment; two West African and one Romanian (22,40,50). The prevalence estimates were similar; 7.0% (95% CI 3 -15) (22), 11.0% (95% CI 8 -15) (40) and 13% (95% CI 7 -23) (50).…”

Section: Prevalence Of Leg Lymphedema Following Gynecological Cancer mentioning

confidence: 97%

“…[Insert Table 3] Leg lymphedema following gynecological cancer treatment All ve studies that reported leg lymphedema used either patient self-report (n=3) or palpation or clinical diagnosis (n=2). Studies which used the self-report method of lymphedema diagnosis only used either palpation or observation methods of identifying lymphedema in the affected limbs of the patients (22,40,49). These were based on patients' reports of swelling in the legs alone.…”

Section: [Insert Figures 2 and 3]mentioning

confidence: 99%

See 2 more Smart Citations

Prevalence and incidence of cancer related lymphedema in low and middle-income countries: A systematic review and meta-analysis.

Torgbenu

Luckett

Buhagiar

et al. 2020

Preprint

View full text Add to dashboard Cite

Abstract Background Little is known about the prevalence and incidence in low and middle-income countries (LMICs) of secondary lymphedema due to cancer. This study aims to estimate the prevalence and incidence in LMICs of secondary lymphedema related to cancer and/or its treatment(s) and identify risk factors. Method A systematic review and meta-analysis was conducted. Medline, EMBASE and CINAHL were searched in June 2019 for peer-reviewed articles that assessed prevalence and/or incidence of cancer-related lymphedema in LMICs. Risk of bias was assessed using the Joanna Briggs Institute Critical Appraisal Checklist for Prevalence Studies. Estimates of pooled prevalence and incidence estimates were calculated with 95% confidence intervals (CI), with sub-group analyses grouping studies according to: country of origin, study design, risk of bias, setting, treatment, and lymphedema site and measurement. Heterogeneity was measured using X ² and I 2 , with interpretation guided by the Cochrane Handbook for Systematic Reviews. Results Of 8766 articles, 36 were included. Most reported on arm lymphedema secondary to breast cancer treatment (n=31), with the remainder reporting on leg lymphedema following gynecological cancer treatment (n=5). Arm lymphedema was mostly measured by arm circumference (n=16/31 studies), and leg lymphedema through self-report (n=3/5 studies). Eight studies used more than one lymphedema measurement. Only two studies that measured prevalence of leg lymphedema could be included in a meta-analysis (pooled prevalence =10.0%, 95%CI 7.0 – 13.0, I 2 =0%). The pooled prevalence of arm lymphedema was 27%, with considerable heterogeneity (95%CI 20.0 – 34.0, I 2 =94.69%, n =13 studies). The pooled incidence for arm lymphedema was 21%, also with considerable heterogeneity (95%CI 15.0 – 26.0, I 2 =95.29%, n =11 studies). There was evidence that higher BMI (>25) was associated with increased risk of arm lymphedema (OR: 1.98, 95%CI 1.45 – 2.70, I 2 =84.0%, P< 0.0001, n =4 studies). Conclusion Better understanding the factors that contribute to variability in cancer-related arm lymphedema in LMICs is an important first step to developing targeted interventions to improve quality of life. Standardising measurement of lymphedema globally and better reporting would enable comparison within the context of information about cancer treatments and lymphedema care.

show abstract

A Retrospective Study on Cervical Cancer Screening Using Pap Smear and Related Factors Among Women Living in Tiaret, Algeria

Chikhaoui

Smail

Aissa

et al. 2020

Indian J Gynecol Oncolog

View full text Add to dashboard Cite

Les carcinomes épidermoïdes du col utérin à l’Institut du cancer de Dakar

Cited by 10 publications

References 0 publications

Dysplasies cervicales chez les femmes séropositives pour le VIH en zone de forte prévalence de l’infection

Dysplasies cervicales chez les femmes séropositives pour le VIH en zone de forte prévalence de l’infection

Prevalence and incidence of cancer related lymphedema in low and middle-income countries: A systematic review and meta-analysis.

A Retrospective Study on Cervical Cancer Screening Using Pap Smear and Related Factors Among Women Living in Tiaret, Algeria

Contact Info

Product

Resources

About